What Are HPV 16 and 18?

What Are HPV 16 and 18?

What Are HPV 16 and 18?
Adobe Stock

Human papillomavirus (HPV) includes many strains of a widespread virus that infects nearly everyone at some point. Each strain has a number, and HPV 16 and 18 are among the most aggressive types, and they significantly increase the risk of cervical, vaginal, and vulvar cancer in women and penile cancer in men. These strains also have links to anal and throat cancers.

In most people, the body naturally sheds infected cells and clears an HPV infection. However, in some, HPV persists, and type 16 or 18 HPV in particular can greatly increase your risk of developing cancer at the infection’s location. However, even high-risk HPV types generally take years to become cancerous.

For women, such slow growth allows screenings known as Pap tests to find and treat precancerous changes in the cervical cells, called dysplasia. More recently, HPV tests have been developed that can detect high-risk types of HPV like 16 and 18 in the cells of the cervix.

HPV Is Common, Yet Commonly Misunderstood

HPV is the most commonly diagnosed sexually transmitted disease (STD) in the United States and abroad. According to StatPearls, around 45.2 percent of men and 39.9 percent of women in the United States ages 18 to 59 have genital HPV.

But even though it’s very common, many people with HPV misunderstand it. The way it transmits between people — often through the genitals — may be the reason behind this.

“Some patients understand that HPV is a sexually transmitted virus, but others focus more on the cancer aspect and may not realize the connection,” says Jessica Wells, PhD, RN, associate professor at Emory University’s Nell Hodgson Woodruff School of Nursing. “I often find myself explaining that HPV is actually very common, and in most cases, the body clears it on its own — nothing ever comes of it.”

Abstinence from any type of sexual activity, including oral, vaginal, and anal sex, is the only 100 percent effective way to prevent HPV transmission.

HPV also causes common skin warts, which doctors don’t consider to be STDs. However, HPV 16 and 18 don’t cause warts. Instead they’re linked to cancer development.

However, Dr. Wells maintains that managing both the virus transmission and cancer aspects through patient education is central to reducing the risk.

“My goal is always to empower patients: Come back for your appointments and follow through with the recommendations, because cervical cancer caused by HPV is almost entirely preventable,” she says. “I think people tend to gloss over the fact that it’s an STD, and their focus naturally goes to the cancer risk. But, with the right education and care, we can manage both the virus and the potential complications that come with it."

How HPV 16 and 18 Differ From Other Strains

The most important difference between HPV 16 and 18 and other strains is that they are highly aggressive and much more likely to cause cancer than other HPV strains.

HPV 16 alone causes around 62.4 percent of cervical cancers, with HPV 18 having the second strongest link, responsible for 15.3 percent of them. Five other types cause more than 2 percent of cervical cancers each, accounting for around 20 percent of cervical cancers combined.

Some HPV tests will specifically look for HPV 16 and 18, due to their risk level compared with other types.

However, the Centers for Disease Control and Prevention (CDC) confirms that while infection with a high-risk HPV strain is necessary for cervical cancer to develop, most females with HPV 16 or 18 don’t develop cancer, since the body still usually clears them.

Does HPV 16 or HPV 18 Cause Genital Warts?

HPV also causes common skin warts, including those on the genitals. However, HPV 16 and 18 don’t cause warts.

 Instead, types 6 and 11 cause around 90 percent of all genital warts.

While HPV 16 and HPV 18 are high-risk types, HPV 6 and HPV 11 are low-risk. That means that while they mainly cause genital warts, they rarely lead to cancers.

How Will I Know if I Have Cervical HPV?

High-risk HPV strains like HPV 16 and HPV 18 don’t show any symptoms on the cervix or elsewhere. For that reason, checkups are crucial to identify whether you have cervical HPV and to find and treat any precancerous cell changes, known as dysplasia.

A test known as a Pap test or Pap smear can highlight those cervical cell changes. An HPV test can find higher-risk HPV strains on the cervix.

Because of the lower risk that HPV poses for young women, the American College of Obstetricians and Gynecologists (ACOG) recommends that women begin Pap testing at age 21 and receive the test every three years, with an option to substitute an HPV test every five years for average-risk females ages 25 to 29 years.

If a woman has a history of normal Pap tests and doesn’t have certain risk factors (such as a compromised immune system), the ACOG says that she should have one of the following tests between 30 and 65 years of age:

  • A Pap test every three years
  • A Pap test and an HPV test together every five years
  • Just an HPV test every five years

Even though HPV is common, many women will never know that they have it, since the cervix often sheds HPV-carrying cells without treatment. This is particularly true of women under 30.

“Many times, when women acquire HPV at a young age, there is a high clearance rate, and they tend to clear it on their own without any need for procedures like colposcopies, which we used to perform a lot in the early 2000s,” says Salena Zanotti, MD, an ob-gyn at the Cleveland Clinic in Avon, Ohio. “This is because our immune systems are definitely more active the younger we are.”

What if I Test Positive for HPV 16 or 18 of the Cervix?

Testing positive for HPV 16 or 18 doesn’t mean you’ll definitely develop cervical cancer — the likelihood that cancer will develop is extremely low, even for those with HPV 16 or 18, but you still shouldn’t ignore a positive high-risk HPV test.

Based on the results of your Pap test and HPV test, your doctor can develop a plan to either treat the dysplasia, carry out further testing to rule out cancer, or recommend more frequent follow-up visits to look for additional changes.

“Paps of the cervix have been tested for a long time, and we know the changes HPV causes in the cervix,” notes Dr. Zanotti, meaning that doctors can often tell which changes to the cervix pose the most immediate danger.

If a Pap smear shows signs of HPV-linked cell changes, or an HPV test is positive for high-risk HPV, a physician or gynecologist can perform a colposcopy to check for cancer or dysplasia cells.

This is a procedure in which your healthcare provider uses a magnifying instrument and bright light to examine the cervix.

If you get diagnosed with HPV, and everything else tests okay, then it is likely that the HPV will clear on its own within one or two years, if you don’t have a suppressed immune system.

What About Screening for Anal HPV?

If you’re concerned about an anal HPV infection, you may find that there isn’t any consistent guidance about potential testing. Zanotti says that research doesn’t recommend screening for anal HPV at the moment.

“Research hasn’t shown that anal HPV screening is more sensitive than anal cytology. Some groups recommend anal cytology for high-risk individuals, but there isn’t a consensus,” cautions Zanotti. She identifies these high-risk groups as:

  • People who have human immunodeficiency virus (HIV)
  • Men who have sex with men
  • Women with a history of high-risk cervical, vulvar, or vaginal dysplasia or cancer
  • Women with a history of cervical HPV 16 infection
  • People with a history of anogenital warts

“These individuals have a higher risk of HPV causing harmful changes, which can lead to cancer,” Zanotti advises. Wells suggests that a woman with a compromised immune system, either due to HIV, lupus, an organ transplant, or another condition, may not clear the virus as efficiently as those with more effective immune systems.

Wells notes that another group has seen an increase in anal cancer.

“Right now, we’re seeing a small but noticeable increase in anal cancer cases among certain groups — specifically, older white women who are not living with HIV,” she outlines. “Traditionally, the group most significantly impacted by anal cancer has been people living with HIV. But this emerging trend in HIV-negative individuals is something we’re keeping an eye on.”

“That said, we’re still not at the point where anal cancer screening is recommended for all women as part of routine cervical cancer screening,” Wells maintains. “There are still some women who may benefit from anal cancer screening.”

If a doctor identifies that you’re in a high-risk group, they may refer you to someone who performs the following tests:

  • Anal cytology testing with HPV co-testing: Similar to the cervical Pap test, this involves collecting cells from the anus using a thin brush or cotton swab. These results can identify unusual cells, but they don’t provide much useful information on their own.

  • High-resolution anoscopy: This procedure uses a microscope to examine physical changes in the anus more closely once a doctor has identified abnormal cells. The health practitioner might also use cell samples for a biopsy to diagnose any cell changes and plan treatment if necessary.
  • Digital anorectal examination: A doctor may insert a gloved, lubricated finger into the anus to feel for abnormal lumps or other signs of cancer.

Wells emphasizes the importance of self-advocacy around anal HPV using a real-life example. “I have a colleague, Lillian Kreppel, who’s an anal cancer survivor.

She’s part of an advocacy group called the HPV Cancers Alliance and shares her story about how her symptoms were initially brushed off by her gynecologist only to later find out it was HPV-related anal cancer,” she says. “Lillian’s now a strong voice for empowering women to speak up when something doesn’t feel right, whether it’s unusual bleeding, persistent pain, or other symptoms that warrant a closer look.”

So in short, while anal Pap tests aren’t recommended for the general population at this time, individuals with certain risk factors might benefit from including that screening alongside their cervical Pap tests.

Rise in HPV 16–Related Throat Cancer

For years, heavy tobacco and alcohol use were the main known risk factors for developing cancer of the oropharynx — the back of the throat, including the base of the tongue and the tonsils.

Today, HPV is the primary cause of oropharyngeal cancer around the world.

In the United States, HPV is thought to cause 70 percent of all oropharyngeal cancers, with HPV 16 being the most common culprit.

And the incidence of HPV-linked oropharyngeal cancer has been steadily increasing by around 1 percent every year, with the death rate similarly increasing by 0.7 percent yearly between 2009 and 2022.

Both oral HPV infection and HPV-related oropharyngeal cancer are much more common among men than women. About 10 percent of American men have oral HPV, compared with 3.6 percent of women, according to the CDC.

The good news is that oropharyngeal cancer caused by HPV has a much higher five-year survival rate after treatment than head and neck cancers not associated with HPV.

HPV Vaccine No 'License for Sex' in Girls

There did not appear to be any difference in the sexual behaviors of adolescent girls who received the human papillomavirus (HPV) vaccine and their unvaccinated peers, researchers found.
HPV Vaccine No 'License for Sex' in Girls

Does the HPV Vaccine Protect Against Types 16 and 18?

In the United States, an HPV vaccine called Gardasil-9 (9vHPV) is available to protect against high-risk HPV strains, including HPV 16 and 18. Some other countries use a different vaccine, Cervarix, which prevents only HPV 16 and 18, or Gardasil, which protects against types 6, 11, 16, and 18. However, HPV 16 and 18 are the only types included in every HPV vaccine.

The CDC recommends that all adolescents get the HPV vaccine at 11 or 12 years of age. It’s also recommended for anyone who wasn’t fully vaccinated at a younger age, up to age 26.

The HPV vaccine is also an option for adults ages 27 to 45 who didn’t receive it earlier. Discuss with your healthcare provider whether it is suitable for you.

Zanotti notes that some parents may be hesitant to give their child the HPV vaccine because HPV is associated with sexual activity.

“I tell my patients, ‘If you vaccinated your child against measles, mumps, and rubella, they’re more likely to get HPV than they are to get rubella these days, and HPV is something that causes cancer.’ It’s pretty clear-cut. If you can do something to prevent the cancer, why wouldn’t you?” Zanotti says.

Zanotti adds that while more parents are getting their sons vaccinated against HPV, this still isn’t as common as vaccination in girls.

“But if in the next 10 years, boys get the vaccine as often, we will see the amount of HPV going down significantly,” she says. “A study from last year showed that adolescents who received the vaccine had zero cases of cervical cancer. That really shows its effectiveness.”

Still, Wells cautions that the HPV vaccine doesn’t do away with the need for safer sexual practices.

“Gardasil 9 only protects against nine HPV types, including the four higher-risk viruses,” says Wells. “There are actually hundreds of different HPV strains out there. So while the vaccine covers the most dangerous and most common ones, it’s not a shield against every single type.”

That’s why Wells encourages people to still practice safe sex.

“Even though your cancer risk is significantly lower with the vaccine, there are other HPV strains — and of course, other STDs — that you could be exposed to,” Wells says. “And for people with a uterus, it’s also vital to protect against unintended pregnancy if that’s a concern. Safe sex offers a whole range of protections — not just against HPV, but for your overall sexual health.”

The Takeaway

  • HPV types 16 and 18 are considered higher risk. They pass between people during sexual activity and can lead to cell changes in the cervix, vagina, vulva, and anus that may become cancerous. However, most people clear HPV long before it causes health problems.
  • The Gardasil 9 vaccine protects against the highest-risk types of HPV, as well as some other types, and it is highly effective.
  • People with HIV or other conditions that affect the immune system may have a higher risk of cancer developing and may also benefit from anal testing.
  • Screening can help doctors identify and remove cells with HPV-linked changes from the cervix and other areas that are concerning. Speak to a healthcare professional about cervical screening and whether you’re a candidate for HPV testing in different areas.
EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
  1. HPV and Cancer. American Cancer Society. May 9, 2025.
  2. Basic Information About HPV and Cancer. Centers for Disease Control and Prevention. September 17, 2024.
  3. Luria L et al. Human Papillomavirus. StatPearls. January 16, 2023.
  4. HPV Prevention. Cook Children’s Medical Center.
  5. HPV (Human Papillomavirus). Cleveland Clinic. October 21, 2024.
  6. Hidjo M et al. Cervical Cancer Microbiome Analysis: Comparing HPV 16 and 18 With Other HPV Types. Scientific Reports. September 24, 2024.
  7. Pink Book Chapter 11: Human Papillomavirus. Centers for Disease Control and Prevention. April 23, 2024.
  8. Leslie SW et al. Genital Warts. StatPearls. May 30, 2023.
  9. Types of HPV. American Cancer Society. April 30, 2024.
  10. What Are the Symptoms of HPV? Planned Parenthood.
  11. Updated Cervical Cancer Screening Guidelines. American College of Obstetricians and Gynecologists. April 2021.
  12. I Have HPV. Now What? MD Anderson Cancer Centre. June 5, 2024.
  13. Colposcopy. Cleveland Clinic. July 29, 2025.
  14. Wells J et al. Anal Cancer: Screening Recommendations for High-Risk Women. Clinical Journal for Nurse Practitioners in Women’s Health. April 2025.
  15. Preventing Anal Cancer. Mount Sinai.
  16. Digital Rectal Exam. Cleveland Clinic. May 7, 2024.
  17. Overcoming Anal Cancer: Lillian’s Story. Memorial Sloan Kettering Cancer Center.
  18. Jamal Z et al. Oropharyngeal Squamous Cell Carcinoma. StatPearls. April 27, 2023.
  19. Key Statistics for Oral Cavity and Oropharyngeal Cancers. American Cancer Society. January 16, 2025.
  20. HPV and Oropharyngeal Cancer. Centers for Disease Control and Prevention. September 17, 2024.
  21. Human HPV and Throat/Oral Cancer Frequently Asked Questions. Mount Sinai.
  22. Human Papillomavirus (HPV) Vaccines. National Cancer Institute. May 25, 2021.
  23. HPV Vaccination. Centers for Disease Control and Prevention. August 20, 2024.
  24. Palmer TJ et al. Invasive Cervical Cancer Incidence Following Bivalent Human Papillomavirus Vaccination: A Population-Based Observational Study of Age at Immunization, Dose, and Deprivation. Journal for the National Cancer Institute. January 22, 2024.
jane-yoon-scott-bio

Jane Yoon Scott, MD

Medical Reviewer

Jane Yoon Scott, MD, is an infectious disease physician and an assistant professor of medicine at Emory University in Atlanta. Dr. Scott enjoys connecting with her patients, empowering them to understand and take ownership of their health, and encouraging them to ask questions so that they can make informed and thoughtful decisions.

She graduated with the highest honors from the Georgia Institute of Technology, then received her MD from the Medical College of Georgia. She completed her internal medicine residency training and chief residency at Temple University Hospital, as well as a fellowship in infectious diseases at Emory University. She is board-certified in both internal medicine and infectious diseases.

When she is not seeing patients, Dr. Scott works with neighboring health departments to promote public health, especially to communities that have been historically underserved. She also teaches medical trainees and lectures medical students at the Emory University School of Medicine.

In her free time, Dr. Scott appreciates a good coffee shop, weekend hikes, playing guitar, strolling through cities, sampling restaurants, and traveling to new places.

Adam Felman

Author
Adam is a freelance writer and editor based in Sussex, England. He loves creating content that helps people and animals feel better. His credits include Medical News Today, Greatist, ZOE, MyLifeforce, and Rover, and he also spent a stint as senior updates editor for Screen Rant.

As a hearing aid user and hearing loss advocate, Adam greatly values content that illuminates invisible disabilities. (He's also a music producer and loves the opportunity to explore the junction at which hearing loss and music collide head-on.)

In his spare time, Adam enjoys running along Worthing seafront, hanging out with his rescue dog, Maggie, and performing loop artistry for disgruntled-looking rooms of 10 people or less.